Ottawa Heart Institute

Running trials

• Not yet recruiting

  Heart tEam Decision-making Assisted by Revaz AI Trial

  NCT07837765· Source

• Not yet recruiting

  Capital Offload-Shock

  NCT07756801· Phase 4· Source

• Not yet recruiting

  Dapagliflozin for Long COVID Syndrome

  NCT06907251· Phase 3· Source

• Not yet recruiting

  Paroxysmal Atrial Fibrillation Repeat Ablation Strategies With Durably Isolated Pulmonary Veins

  NCT07910825· Source

• Recruiting

  Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension

  NCT06405555· Phase 2/3· Source

• Recruiting

  Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation

  NCT04823299· Source

• Recruiting

  Semaglutide for Smoking Cessation in Patients With Diabetes

  NCT07059377· Phase 3· Source

• Recruiting

  Improving Care and Mental Well-Being for Adults With Heart Failure

  NCT07313657· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Source

• Recruiting

  MAX - SHOCK Clinical Trial

  NCT06556667· Source

• Recruiting

  Prevail Global Study

  NCT06535854· Source

• Active, not recruiting

  Impact of Automatic Prompts in Echocardiographic Reports on Referral to Cardiology

  NCT06816888· Source

• Recruiting

  Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale

  NCT06670781· Source

• Recruiting

  Exercise Training in Women With Heart Disease 2

  NCT06494163· Source

• Recruiting

  Dapagliflozin in STEMI

  NCT06174753· Phase 3· Source

• Recruiting

  LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY

  NCT06547788· Source

• Recruiting

  Canagliflozin Targeting Vascular Inflammation

  NCT05427084· Phase 2/3· Source

• Active, not recruiting

  Abbott Medical - VERITAS Study

  NCT06707688· Source

• Recruiting

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  NCT06274801· Phase 3· Source

• Recruiting

  One-Month DAPT in CABG Patients

  NCT05997693· Phase 3· Source

• Recruiting

  Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

  NCT06249269· Source

• Recruiting

  The STOP-MED CTRCD Trial

  NCT06183437· Phase 4· Source

• Recruiting

  Exercise Testing Protocols for Females and Males With CAD

  NCT06179212· Source

• Recruiting

  Florbetaben for Imaging of Vascular Amyloid

  NCT06091319· Source

• Active, not recruiting

  CTSN Embolic Protection Trial

  NCT06027788· Source

• Recruiting

  Left vs Left Randomized Clinical Trial

  NCT05650658· Source

• Recruiting

  The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

  NCT05427370· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Source

• Active, not recruiting

  Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

  NCT05632601· Source

• Recruiting

  Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  NCT04124120· Source

• Recruiting

  QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)

  NCT05136131· Source

• Recruiting

  Aggressive Smoking Cessation Trial (ASAP)

  NCT05257629· Phase 3· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· Source

• Active, not recruiting

  Feasibility of High-Intensity Interval Nordic Walking in Patients With Coronary Artery Disease

  NCT05434117· Source

• Recruiting

  Predicting Development of SCAF in Device Patients

  NCT02808260· Source

• Active, not recruiting

  An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation

  NCT05157932· Source

• Active, not recruiting

  Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease

  NCT05037799· Source

• Recruiting

  Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

  NCT05298124· Source

• Active, not recruiting

  Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

  NCT05069558· Source

• Recruiting

  CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

  NCT05267886· Phase 4· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Active, not recruiting

  REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial

  NCT04822675· Source

• Recruiting

  COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

  NCT04642430· Phase 4· Source

• Active, not recruiting

  STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

  NCT04428944· Source

• Recruiting

  Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository

  NCT05100420· Source

• Active, not recruiting

  Amplatzer Amulet LAAO vs. NOAC

  NCT04226547· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Source

• Recruiting

  Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  NCT04045665· Phase 3· Source

• Active, not recruiting

  Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)

  NCT04000607· Source

• Active, not recruiting

  Reversal of Atrial Substrate to Prevent Atrial

  NCT03682991· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease12 recruiting
• Atrial fibrillation8 recruiting
• Heart failure7 recruiting
• Stroke4 recruiting
• Type 2 diabetes3 recruiting
• High blood pressure1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Long COVID and ME/CFS1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS

  NCT06272981· Source

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· Source

• Terminated

  IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

  NCT06139328· Phase 2· Source

• Withdrawn

  Rivet PVS Therapy in Group 2 PH-HFpEF Canada

  NCT05332873· Source

• Completed

  Acorai Machine Learning Generalization (MLG) Study

  NCT05835024· Source

• Completed

  Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend

  NCT05118893· Source

• Completed

  Blood Flow Reserve: Effects After Training With Heavy Inspiratory Exercises

  NCT05632614· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care

  NCT05300503· Source

• Completed

  RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

  NCT05134012· Phase 3· Source

• Completed

  Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation

  NCT05085860· Source

• Completed

  Exercise Training in Women With Heart Disease

  NCT04781504· Source

• Completed

  Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)

  NCT04494347· Source

• Completed

  Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus

  NCT04223505· Source

• Terminated

  Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

  NCT03729401· Phase 4· Source

• Completed

  HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection

  NCT03575910· Source

• Completed

  Spironolactone Therapy in Chronic Stable Right HF Trial

  NCT03344159· Phase 4· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· Source

• Completed

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· Phase 3· Source

• Completed

  Peer Support for Women With Heart Disease: Women@Heart

  NCT03286010· Source

• Completed

  Sub-Clinical Atrial Fibrillation Biomarker Study

  NCT02840201· Source

• Terminated

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Source

• Completed

  CardiAMP™ Cell Therapy for Heart Failure Trial

  NCT02438306· Phase 3· Source

• Completed

  Antiarrhythmics or Ablation for Ventricular Tachycardia 2

  NCT02830360· Phase 4· Source

• Completed

  Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training

  NCT02627183· Source

• Completed

  Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

  NCT02168829· Phase 4· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Source

• Terminated

  Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

  NCT02387229· Phase 3· Source

• Completed

  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

  NCT02100722· Source

• Completed

  Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

  NCT01994252· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· Source

• Completed

  Cardiac FDG PET Viability Registry

  NCT00766987· Source

Trial sites

• 1240077 - Ottawa Heart Institute1 trial
• Division of Cardiac Surgery, University of Ottawa Heart Institute1 trial
• Ottawa Heart Institute10 trials
• The University of Ottawa Heart Institute2 trials
• University of Ottawa Heart Institute78 trials
• University Ottawa Heart Institute1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Coronary artery disease45 works · 35 trials